Regeneron Is Now A Sell For Chardan

By: via Benzinga
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) shares have been trending south so far in 2016 and are down 11 percent since ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.